Survival analysis of AIDS in-patients at Joint Clinical Research Centre, Uganda
作者： L.K. Atuhaire , J.O. Odwee , T. Otim
DOI:
关键词:
摘要: Sub-Saharan Africa saw the first introduction of antiretroviral (ARV) drugs in an organized manner at Joint Clinical Research Centre (JCRC) Uganda as early 1992 when it conducted ART trial Africa. By June 2002 there were 16 commercially available medications (WHO, 2002) and JCRC is following biggest number patients on ARVs rest (Mugyenyi, 2003). The goals are to prevent immunological decline clinical progression so doing prolong survival improve quality life by suppressing viral load for long possible.
princeton.edu参考文章(15)
Cynthia A. Kleeberger, John P. Phair, Steffanie A. Strathdee, Roger Detels, Lawrence Kingsley, Lisa P. Jacobson, Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. Journal of Acquired Immune Deficiency Syndromes. ,vol. 26, pp. 82- 92 ,(2001) , 10.1097/00126334-200101010-00012
Richard E. Chaisson, Jeanne C. Keruly, Richard D. Moore, Race, sex, drug use, and progression of human immunodeficiency virus disease The New England Journal of Medicine. ,vol. 333, pp. 751- 756 ,(1995) , 10.1056/NEJM199509213331202
Dennis Israelski, Cheryl Gore-Felton, Rachel Power, Mary Jane Wood, Cheryl Koopman, Sociodemographic characteristics associated with medical appointment adherence among HIV-seropositive patients seeking treatment in a county outpatient facility. Preventive Medicine. ,vol. 33, pp. 470- 475 ,(2001) , 10.1006/PMED.2001.0917
Elias Kassa, Tobias F. Rinke de Wit, Ermias Hailu, Mulu Girma, Tsehaynesh Messele, Hiruy Gebre Mariam, Semere Yohannes, Suzanne Jurriaans, Hailu Yeneneh, Roel A. Coutinho, Arnaud L. Fontanet, Evaluation of the World Health Organization staging system for HIV infection and disease in ethiopia : Association between clinical stages and laboratory markers AIDS. ,vol. 13, pp. 381- 389 ,(1999) , 10.1097/00002030-199902250-00011
Richard D. Moore, Richard E. Chaisson, Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS. ,vol. 13, pp. 1933- 1942 ,(1999) , 10.1097/00002030-199910010-00017
Dennis Osmond, Edwin Charlebois, William Lang, Stephen Shiboski, Andrew Moss, Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. JAMA. ,vol. 271, pp. 1083- 1087 ,(1994) , 10.1001/JAMA.1994.03510380039034
Marcia McDonnell, Joan Turner, Michael T. Weaver, Antecedents of Adherence to Antituberculosis Therapy Public Health Nursing. ,vol. 18, pp. 392- 400 ,(2001) , 10.1046/J.1525-1446.2001.00392.X
Mark Harrington, Charles CJ Carpenter, Hit HIV-1 hard, but only when necessary The Lancet. ,vol. 355, pp. 2147- 2152 ,(2000) , 10.1016/S0140-6736(00)02388-6
H. Valdez, T. K. Chowdhry, R. Asaad, I. J. Woolley, T. Davis, R. Davidson, N. Beinker, B. M. Gripshover, R. A. Salata, G. McComsey, S. B. Weissman, M. M. Lederman, Changing Spectrum of Mortality Due to Human Immunodeficiency Virus: Analysis of 260 Deaths during 1995–1999 Clinical Infectious Diseases. ,vol. 32, pp. 1487- 1493 ,(2001) , 10.1086/320164
Kathryn Anastos, Yolanda Barrón, Paolo Miotti, Barbara Weiser, Mary Young, Nancy Hessol, Ruth M Greenblatt, Mardge Cohen, Michael Augenbraun, Alexandra Levine, Alvaro Muñoz, Women's Interagency HIV Study Collaborative Study Group, Risk of Progression to AIDS and Death in Women Infected With HIV-1 Initiating Highly Active Antiretroviral Treatment at Different Stages of Disease JAMA Internal Medicine. ,vol. 162, pp. 1973- 1980 ,(2002) , 10.1001/ARCHINTE.162.17.1973